发明名称 |
DDX3 as a biomarker for cancer and methods related thereto |
摘要 |
The invention encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer or tumor growth, by administering to a subject in need thereof a composition comprising a therapeutically or prophylactically effective amount of a compound that downregulates DDX3, for example a fused diimidazodiazepine ring compound or a pharmaceutically acceptable salt thereof. The invention also encompasses the use of DDX3 as a biomarker for diagnostic and treatment purposes, for example, to identify a hyperproliferative disorder susceptible to treatment by down regulation of DDX3. |
申请公布号 |
US9322831(B2) |
申请公布日期 |
2016.04.26 |
申请号 |
US201313840549 |
申请日期 |
2013.03.15 |
申请人 |
The Johns Hopkins University |
发明人 |
Raman Venu;Bol Guus Martinus;Van Diest Paul Joannes |
分类号 |
C07D487/14;G01N33/68;G01N33/574;A61K31/551 |
主分类号 |
C07D487/14 |
代理机构 |
Venable LLP |
代理人 |
Venable LLP ;Haddaway Keith G.;Kwok Annette K. |
主权项 |
1. A method of treating a hyperproliferative disorder susceptible to treatment by downregulation of DDX3 comprising administering to a subject in need thereof an effective amount of a composition or formulation comprising a compound of Formula (IV), wherein such compound downregulates DDX3, and wherein the compound of Formula (IV) is:or pharmaceutically acceptable salts and prodrugs thereof,wherein:
R3 and R4 are each independently a hydrogen; hydroxyl; substituted or unsubstituted: cyclic or acyclic alkyl group, cyclic or acyclic alkenyl group, cyclic or acyclic alkynyl group, aryl group, alkylary group, aryalkyl group, benzyl group, cyclic or acyclic heteroalkyl group, heteroaryl group. |
地址 |
Baltimore MD US |